Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Gaucher disease, the most common lysosomal storage disease, is caused by a deficiency of glucocerebrosidase resulting in the impairment of glucosylceramide degradation.The hallmark of the disease is the presence of the Gaucher cell, a macrophage containing much of the stored glucosylceramide found in tissues, which is believed to cause many of the clinical manifestations of the disease.We have developed adult mice carrying the Gaucher disease L444P point mutation in the glucocerebrosidase (Gba) gene and exhibiting a partial enzyme deficiency.The mutant mice demonstrate multisystem inflammation, including evidence of B cell hyperproliferation, an aspect of the disease found in some patients.However, the mutant mice do not accumulate large amounts of glucosylceramide or exhibit classic Gaucher cells in tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak, C. E., van Weely, S., van Oers, M. H., & Aerts, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117084 · Cited by 896 · cited 2×
“Chitotriosidase, an enzyme that is massively elevated in the serum of Gaucher disease patients (28), was modestly elevated in the serum of the mutant mice.”
A vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Self-citationMice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome
Le, L. Q., Kabarowski, J. H. S., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., Miller, J. F., & Witte, O. N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00145-5 · Cited by 215 · cited 2×
“G protein–coupled receptors for sphingolipids have been shown to regulate the activity of cells of the immune system (35, 36).”
Research works printed but not linked: 32
- Brady, 1974, N Engl J Med, 291, 989, 10.1056/NEJM197411072911901 · DOI · Paper page
- 10.1073/pnas.74.10.4620 · DOI
- Barton, 1991, N Engl J Med, 324, 1464, 10.1056/NEJM199105233242104 · DOI · Paper page
- 10.1016/S0140-6736(00)02161-9 · DOI · Paper page
- 10.2174/1389200013338414 · doi:10.2174/1389200013338414
- 10.1093/glycob/10.12.1249 · DOI
- 10.1023/A:1010335505357 · DOI
- Cox, 2001, J Inherit Metab Dis, 24, 106
- 10.1002/ajh.2830290403 · DOI
- Marie, 1982, Scand J Haematol, 28, 54, 10.1111/j.1600-0609.1982.tb02120.x · doi:10.1111/j.1600-0609.1982.tb02120.x
- Barak, 1999, Eur Cytokine Netw, 10, 205
- 10.1006/bcmd.1997.0156 · DOI
- Allen, 1997, QJM, 90, 19, 10.1093/qjmed/90.1.19 · DOI · Paper page
- Michelakakis, 1996, Biochim Biophys Acta, 1317, 219, 10.1016/S0925-4439(96)00056-7 · DOI
- 10.1097/00003072-198511000-00018 · doi:10.1097/00003072-198511000-00018
- Shoenfeld, 1982, Arch Pathol Lab Med, 106, 388
- Burstein, 1985, Scand J Haematol, 35, 445, 10.1111/j.1600-0609.1985.tb02269.x · doi:10.1111/j.1600-0609.1985.tb02269.x
- 10.1002/1097-0142(19840715)54:2<312::AID-CNCR2820540222>3.0.CO;2-I · doi:10.1002/1097-0142(19840715)54:2<312::aid-cncr2820540222>3.0.co;2-i
- 10.1038/357407a0 · DOI · Paper page
- 10.1073/pnas.95.5.2503 · DOI · Paper page
- 10.1172/JCI117160 · DOI · Paper page
- 10.1073/pnas.97.20.10954 · DOI · Paper page
- 10.1038/ng1196-348 · DOI · Paper page
- Momoi, 1976, Biochim Biophys Acta, 441, 488, 10.1016/0005-2760(76)90245-9 · DOI · Paper page
- Shayman, 1991, J Biol Chem, 266, 22968, 10.1016/S0021-9258(18)54449-5 · DOI
- 10.1073/pnas.61.2.484 · DOI · Paper page
- Ginsberg, 1984, Clin Genet, 26, 109, 10.1111/j.1399-0004.1984.tb00799.x · DOI
- 10.1016/0026-0495(88)90102-3 · DOI
- Moran, 2000, Blood, 96, 1969, 10.1182/blood.V96.5.1969 · DOI · Paper page
- 10.1046/j.1365-2796.1999.00607.x · doi:10.1046/j.1365-2796.1999.00607.x
- 10.1126/science.1061781 · DOI · Paper page
- 10.1083/jcb.153.2.429 · DOI · Paper page
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“Mice carrying GBA L444P mutation exhibited partial enzyme deficiency, which then led to multisystem inflammation.(265) These results indicate that GBA dysfunction leads to immune dysfunction which may be responsible for the development of both idiopathic and GBAassociated PD.”
BackgroundInflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Ceramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Self-citationBoven, L. A., van Meurs, M., Boot, R. G., Mehta, A. B., Boon, L., Aerts, J. M. F. G., & Laman, J. D. (2004) · American Journal of Clinical Pathology · doi:10.1309/bg5v-a8jr-dqh1-m7hn · Cited by 290
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222
Viable Mouse Models of Acid β-Glucosidase Deficiency
Xu, Y.-H., Quinn, B., Witte, D., & Grabowski, G. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63566-3 · Cited by 170
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
Schiffer, V., Santiago-Mujika, E., Flunkert, S., Schmidt, S., Farcher, M., Loeffler, T., Schilcher, I., Posch, M., Neddens, J., Sun, Y., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227077 · Cited by 11
Metadata
- Authors
- Mizukami, H., Mi, Y., Wada, R., Kono, M., Yamashita, T., Liu, Y., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 9
- Pages
- 1215-1221
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4234282571
- Cited by
- 125
- References
- 3
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.